SPRY

ARS PHARMACEUTICALS INC

Healthcare | Small Cap

-$0.50

EPS Forecast

$24.59

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.50

Revenue Forecast:

$24.59

EPS Surprise Forecast:

-$0.006

Revenue Surprise Forecast:

$1

Post-release price volatility - Very high

Post-release Overnight Move:

±10.8%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

49%

Probability of beating revenue consensus:

65%

Probability of beating both EPS & revs consensus:

38%

Probability of missing both EPS & revs consensus:

24%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-2

Beta (β)

Forward Looking Beta (β):

1.52

Earnings volatility

EPS standard deviation:

$0.24

Revenue standard deviation:

$8

As % of share price:

2.92% VERY HIGH

As % of market cap:

0.94% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.20

Revenue 95th %ile:

$34

EPS 75th %ile:

-$0.42

Revenue 75th %ile:

$27

EPS 25th %ile:

-$0.57

Revenue 25th %ile:

$23

EPS 5th %ile:

-$0.78

Revenue 5th %ile:

$17

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

39% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

100% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$27

Bid-ask per Share:

$0.02